Correspondingly, a single STAT responsive element has been identified within the MUC1 promoter, that when mutated both decreases MUC1 promoter activity in breast cancer cells and also abolishes stimulation by interleukin-6 and interferon-gamma [35]. Here, IL6 is linked to breast carcinoma.